A detailed history of Caption Management, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Caption Management, LLC holds 89,200 shares of PTGX stock, worth $3.62 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
89,200
Holding current value
$3.62 Million
% of portfolio
0.07%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$33.72 - $47.33 $745,212 - $1.05 Million
22,100 New
22,100 $993,000
Q2 2023

Aug 14, 2023

BUY
$18.02 - $29.36 $340,523 - $554,815
18,897 Added 7776.54%
19,140 $528,000
Q1 2023

May 15, 2023

SELL
$10.78 - $25.38 $428,580 - $1.01 Million
-39,757 Reduced 99.39%
243 $5,000
Q3 2022

Nov 14, 2022

BUY
$7.86 - $11.71 $232,656 - $346,616
29,600 Added 284.62%
40,000 $337,000
Q2 2022

Aug 15, 2022

SELL
$7.06 - $25.52 $420,776 - $1.52 Million
-59,600 Reduced 85.14%
10,400 $82,000
Q1 2022

May 13, 2022

SELL
$23.34 - $36.08 $2.86 Million - $4.43 Million
-122,702 Reduced 63.67%
70,000 $1.66 Million
Q4 2021

Feb 11, 2022

BUY
$17.63 - $37.1 $1.46 Million - $3.07 Million
82,702 Added 75.18%
192,702 $6.59 Million
Q3 2021

Nov 12, 2021

BUY
$12.95 - $49.69 $1.42 Million - $5.47 Million
110,000 New
110,000 $1.95 Million

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.99B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.